(S (NP (NP (NP (DT The) (NML (JJ high) (NN risk)) (NN population)) (PP (IN of) (NP (JJ cardiovascular) (NN disease)))) (-LRB- -LRB-) (NP (NNS CVD)) (-RRB- -RRB-)) (VP (VBZ is) (ADVP (RB simultaneously)) (PP (IN at) (NP (NP (JJ high) (NN risk)) (PP (IN of) (NP (NN lung) (NN cancer)))))) (. .))
(S (PP (VBN Given) (NP (NP (DT the) (NN dominance)) (PP (IN of) (NP (NP (NML (JJ low) (NN dose)) (VBN computed) (NN tomography) (PRN (-LRB- -LRB-) (NP (NN LDCT)) (-RRB- -RRB-))) (PP (IN for) (NP (NML (NN lung) (NN cancer)) (NN screening))))))) (, ,) (NP (NP (DT the) (NN feasibility)) (PP (IN of) (S (VP (VBG extracting) (NP (NN information)) (PP (IN on) (NP (NP (NNS CVD)) (PP (IN from) (NP (DT the) (JJ same) (NN LDCT) (NN scan))))))))) (VP (MD would) (VP (VB add) (NP (JJ major) (NN value)) (PP (IN to) (NP (NP (NNS patients)) (PP (IN at) (NP (DT no) (JJ additional) (NN radiation) (NN dose))))))) (. .))
(S (ADVP (RB However)) (, ,) (PP (PP (IN with) (NP (NP (JJ strong) (NN noise)) (PP (IN in) (NP (NN LDCT) (NNS images))))) (CC and) (PP (IN without) (NP (NN electrocardiogram) (NML (-LRB- -LRB-) (NN ECG) (-RRB- -RRB-) (NN gating))))) (, ,) (NP (NP (NNS CVD) (NML (NN risk) (NN analysis))) (PP (IN from) (NP (NNP LDCT)))) (VP (VBZ is) (ADJP (RB highly) (JJ challenging))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP present) (NP (DT an) (JJ innovative) (NML (JJ deep) (NN learning)) (NN model)) (S (VP (TO to) (VP (VB address) (NP (DT this) (NN challenge)))))) (. .))
(S (S (NP (PRP$ Our) (JJ deep) (NN model)) (VP (VP (VBD was) (VP (VBN trained) (PP (IN with) (NP (CD 30,286) (NN LDCT) (NNS volumes))))) (CC and) (VP (VBD achieved) (NP (DT the) (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NN performance) (PRN (-LRB- -LRB-) (NP (NP (NN area)) (PP (IN under) (NP (NP (NP (DT the) (NN curve)) (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-)) (PP (IN of) (NP (CD 0.869)))))) (-RRB- -RRB-))) (PP (IN on) (NP (CD 2,085) (NML (NNP National) (NNP Lung) (NNP Cancer) (NNP Screening) (NNP Trial)) (PRN (-LRB- -LRB-) (NP (NNP NLST)) (-RRB- -RRB-)) (NNS subjects)))))) (, ,) (CC and) (SINV (ADVP (RB effectively)) (VP (VBD identified) (NP (NNS patients)) (PP (IN with) (NP (JJ high) (NNS CVD)))) (NP (NP (NN mortality) (NNS risks)) (-LRB- -LRB-) (NP (NP (NN AUC)) (PP (IN of) (NP (CD 0.768)))) (-RRB- -RRB-))) (. .))
(S (NP (PRP$ Our) (JJ deep) (NN model)) (VP (VBD was) (NP (NP (NP (JJ further) (ADJP (VBN calibrated) (PP (IN against) (NP (NP (DT the) (JJ clinical) (NN gold)) (NP (JJ standard) (NNS CVD))))) (NN risk) (NNS scores)) (PP (IN from) (NP (JJ ECG-gated) (JJ dedicated) (JJ cardiac) (NN CT)))) (, ,) (PP (VBG including) (NP (NP (NML (NML (JJ coronary) (NN artery) (NN calcification)) (-LRB- -LRB-) (NML (NN CAC)) (-RRB- -RRB-)) (NN score)) (, ,) (NP (NML (NN CAD) (HYPH -) (NN RADS)) (NN score)) (CC and) (NP (NP (NNP MESA) (NML (CD 10) (HYPH -) (NN year)) (NN CHD) (NN risk) (NN score)) (PP (IN from) (NP (NP (DT an) (JJ independent) (NN dataset)) (PP (IN of) (NP (CD 106) (NNS subjects)))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN validation) (NN study))) (, ,) (NP (PRP$ our) (NN model)) (VP (VBD achieved) (NP (NP (NN AUC)) (PP (IN of) (NP (CD 0.942) (, ,) (CD 0.809) (CC and) (CD 0.817)))) (PP (IN for) (NP (NP (NN CAC)) (, ,) (NP (NN CAD) (HYPH -) (NN RADS)) (CC and) (NP (NNP MESA) (NNS scores)))) (, ,) (ADVP (RB respectively))) (. .))
(S (NP (PRP$ Our) (NML (JJ deep) (NN learning)) (NN model)) (VP (VBZ has) (NP (DT the) (ADJP (JJ potential) (S (VP (TO to) (VP (VB convert) (NP (NP (NN LDCT)) (PP (IN for) (NP (NML (NN lung) (NN cancer)) (NN screening)))) (PP (IN into) (NP (JJ dual) (HYPH -) (NN screening))))))) (NML (NML (NML (JJ quantitative) (NN tool)) (PP (IN for) (NP (NNS CVD)))) (NN risk)) (NN estimation))) (. .))
